References and Notes
-
1a
Wall ME.
Wani MC.
Cook CE.
Palmer KH.
McPhail AT.
Sim GA.
J.
Am. Chem. Soc.
1966,
88:
3888
-
1b
Govindachari TR.
Viswanathan N.
Indian.
J. Chem.
1972,
10:
453
-
1c
Ma ZZ.
Hano Y.
Nomura T.
Chen YJ.
Heterocycles
1997,
46:
541
-
1d
Ma ZZ.
Hano Y.
Nomura T.
Chen YJ.
Heterocycles
1999,
51:
1883
- 2
Ali MM.
Tasneem KC.
Rajanna PK.
.
Synlett
2001,
251
-
3a
Amin AH.
Mehta DR.
Samarth SG.
Prog. Drug Res.
1970,
14:
218
-
3b
Johne S.
Prog.
Drug Res.
1982,
26:
259
- 4
Cagir A.
Jones SH.
Gao R.
Eisenhauer BM.
Hecht SM.
J. Am. Chem. Soc.
2003,
125:
13628
-
5a
Zhao H.
Lee C.
Sai P.
Choe YH.
Boro M.
Pendri A.
Guan S.
Greenwald RB.
J. Org. Chem.
2000,
65:
4601
-
5b
Fassberg J.
Stella VJ.
J. Pharm. Sci.
1992,
81:
676
-
5c
Burke TG.
Mi Z.
Anal. Biochem.
1993,
212:
285
-
5d
Burke TG.
Mi Z.
J. Med. Chem.
1994,
37:
40
-
6a
Suresh Babu M.
Raghunadh A.
Anil Kumar N.
Syam Kumar UK.
Vasu Dev R.
Dubey PK.
J. Heterocycl.
Chem.
2010,
47: in
press
-
6b
Sawada S.
Okajima S.
Aiyama R.
Nokota K.
Furuta T.
Yokokura T.
Sugino E.
Yamaguchi K.
Miyasaka T.
Chem.
Pharm. Bull.
1991,
39:
1446
-
6c
Kingsbury WD.
Boehm JC.
Jacas DR.
Holden KG.
Hecht SM.
Gallagher G.
Caranfa MJ.
McCabe FL.
Faucette LF.
Johnson
RP.
Hertzberg RP.
J.
Med. Chem.
1991,
34:
98
-
6d Subrahmanyam D, Venkateswarlu A, Sarma VM, Sastry TVRS, Krishna CV, and Madabhushi S. inventors; US 6177439 B1.
-
6e
Subrahmanyam D.
Sarma VM.
Venkateswarlu A.
Sastry TVRS.
Srinivas ASSV.
Krishna CV.
Deevi DS.
Kumar SA.
Babu MJ.
Damodaran NK.
Bioorg. Med. Chem.
Lett.
2000,
10:
369
-
6f
Subrahmanyam D.
Venkateswarlu A.
Venkateswarao K.
Sastry TVRS.
Vandana G.
Kumar SA.
Bioorg. Med.
Chem. Lett.
1999,
9:
1633
-
6g
Kim D.-K.
Lee N.
Mini Rev. Med. Chem.
2002,
2:
611
-
6h
Hatefi A.
Amsden B.
Pharm. Res.
2002,
19:
1389
-
7a
Servais A.
Azzouz M.
Lopes D.
Courillon C.
Malacria M.
Angew. Chem. Int. Ed.
2007,
46:
576
-
7b
Beaume A.
Courillon C.
Derat E.
Malacria M.
Chem. Eur. J.
2008,
16:
1228
- 8
Twin H.
Batey R.
Org. Lett.
2004,
6:
4913
-
9a
Nacro K.
Zha CC.
Guzzo PR.
Herr J.
Peace D.
Friedrich TD.
Bioorg.
Med. Chem.
2007,
13:
4237
-
9b
Harayama T.
Hori A.
Serban G.
Morikami Y.
Matsumoto T.
Abe H.
Takeuchi Y.
Tetrahedron
2004,
60:
10645
-
9c
Mason JJ.
Bergman J.
Org. Biomol.
Chem.
2007,
5:
2486
-
9d
Mhaske SB.
Argade NP.
J.
Org. Chem.
2004,
69:
4563
-
9e
Chavan SP.
Sivappa R.
Tetrahedron
2004,
60:
9931
-
9f
Mhaske SB.
Argade
PN.
J.
Org. Chem.
2004,
69:
4563
- 10
Zhou H.-B.
Liu G.-S.
Yao Z.-J.
J.
Org. Chem.
2007,
73:
6270
- 11
Sridharan V.
Ribelles P.
Ramos T.
Menendez JC.
J. Org.
Chem.
2009,
74:
5715
-
12a
Baruah B.
Bhuyan JP.
Tetrahedron
2009,
65:
7099
-
12b
Baruah B.
Deb ML.
Bhuyan PJ.
Synlett
2007,
1873
-
13a
Jana GP.
Ghorai BK.
Tetrahedron
2007,
63:
12015
-
13b
Chavan SP.
Pasupathy K.
Sivappa R.
Venkatraman MS.
Synth.
Commun
. 2004,
34:
3099
-
13c
Chavan SP.
Sivappa R.
Tetrahedron
Lett.
2004,
45:
3113
- 14
Takao S.
Kazutoshi O.
J. Chem. Soc., Perkin Trans.
1
1999,
16:
2323
15 To a suspension of 2-cyanoquinoline-3-acetal
(9, 1 g, 0.004 mol, 1 equiv) in AcOH (10
mL), methyl anthranilate (0.7 g, 0.005 mol, 1.05 equiv) was added,
and the reaction mixture was heated to reflux for a period of 12-14
h. The reaction mass was then cooled, the precipitated product was
filtered off, and further purified by column chromatography using EtOAc
and hexane (7:3) to yield the lutonin B. The filtrate was diluted
with H2O, and extracted with EtOAc, and dried. Concentration
and purification by column chromatography yielded 11.
16 To a suspension of cyanoaldehyde (1
g, 0.5 mmol, 1 equiv) in AcOH (10 mL) and Ac2O (0.2 mL),
methyl anthranilate (0.554 g, 0.71 mmol, 1.5 equiv) was added, and
the reaction mixture was heated to reflux for a period of 12-14
h. The reaction mass was then cooled to r.t., and precipitated product
was filtered off. The mother liquor was then diluted with H2O,
and extracted with EtOAc. The precipitated product mixture and the
EtOAc extracts were combined together, concentrated under vacuum.
The product was then purified by column chromatography using EtOAc
and hexane (7:3), and pure luotonin B was isolated as white to off-white
solid in 0.890 g, 54% of yield. Also 12% of 11 was also isolated from the column.
17
Methyl-2-(11-oxo-11,13-dihydroquinolino[2′,3′:3,4]-pyrrolo[2,1-
b
]quinazolin-13-yl)amino
benzoate (11)
Yield 20%; mp 312-314 ˚C. ¹H
NMR (400 MHz, CDCl3):
δ = 3.80
(s, 3 H), 6.77 (t, J = 7.2
Hz, 1 H), 7.26 (s, 1 H), 7.27 (s, 1 H), 7.35 (t, J = 7.6
Hz, 1 H), 7.52 (t, J = 6.8
Hz, 1 H), 7.69 (t, J = 7.6
Hz, 1 H), 7.80-7.97 (m, 4 H), 8.1 (d, J = 8.0 Hz,
1 H), 8.34 (dd, J = 1.6,
7.8 Hz, 1 H), 8.48 (s, 1 H) 8.52 (d, J = 8.8
Hz, 1 H), 8.85 (d, J = 9.6
Hz, 1 H). ¹³C NMR (400 MHz, CDCl3): δ = 51.8,
68.4, 112, 113.6, 117.6, 122.4, 126.7, 127.6, 128.4, 128.6, 128.8,
129.1, 130.8, 131.2, 131.7, 132.2, 132.6, 134.4, 134.6, 148.0, 149.0,
150.0, 150.4, 151.4, 160.6, 168.9. MS: m/z (%) = 435 [M + 1], 302.2,
137.1. Anal Calcd for C26H18N4O3:
C, 71.88; H, 4.18; N, 12.90. Found: C, 71.86; H, 4.15; N, 12.87.
18 Luotonin B (2)
Yield
0.89 g (54%); mp 273-275 ˚C.
IR (KBr): 1028, 1266, 1449, 2041, 2945, cm-¹. ¹H
NMR (400 MHz, DMSO-d
6):
δ = 6.98
(d, J = 8.4
Hz, 1 H), 7.62-7.66 (m, 2 H), 7.78 (t, J = 7.2
Hz, 1 H), 7.92-7.96 (m, 3 H), 8.23 (d, J = 8.0
Hz, 1 H), 8.28 (dd, J = 3.6
Hz, 8.4 Hz, 2 H), 8.80 (s, 1 H). ¹³C NMR
(400 MHz, DMSO-d
6): δ = 80.5,
122.2, 126.1, 127.5, 128.2, 128.3, 128.7, 128.8, 129.6, 131.0, 132.8,
133.8, 134.7, 148.7, 149.1, 150.3, 151.5, 159.4. MS m/z (%) = 302.1 [M + 1],
246.2, 150.1. Anal Calcd for C18H11N3O2:
C, 71.75; H, 3.68; N, 13.95. Found: C, 71.77; H, 3.69; N, 13.90.
19 To a solution of luotonin B (0.35
g, 0.16 mol, 1 equiv) in MeOH (3.5 mL, 10 V), Indion resin (0.1
g, 0.01 mmol, 0.1 equiv) was added, and the reaction mixture was
heated at 55 ˚C for a period of 6-7 h.
The reaction mixture was then cooled, and the resin was filtered
off and washed with MeOH (1 mL). The filtrate was concentrated under
reduced pressure, and purified on a filter column using EtOAc-hexane
(30:70). The product was isolated as a white to off-white solid
in 80% (0.29 g) yield.
Luotonin
E
Yield 0.29 g (80%).; mp 222-224 ˚C.
IR (KBr): 1047, 1237, 1300, 1375, 1730, 2985 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 3.60 (s,
3 H), 6.90 (s, 1 H), 7.58 (dt, J = 0.8,
7.6, 11.2 Hz, 1 H), 7.71 (t, J = 6.8
Hz, 1 H), 7.82-7.88 (m, 2 H), 7.99 (d, J = 8.4
Hz, 1 H), 8.09 (d, J = 8.0
Hz, 1 H) 8.41 (dd, J = 1.2, 8.0
Hz, 1 H), 8.47 (d, J = 8.4
Hz, 1 H), 8.5 (s, 1 H). ¹³C NMR (400
MHz, CDCl3): δ = 56.3, 87.0, 122.2,
126.8, 127.8, 128.4, 128.6, 128.8, 130.0, 130.7, 131.3, 133.0, 134.8, 148.9,
150.4, 151.3, 160.7. MS: m/z (%) = 316.2 [M + 1], 279.2,
130.2. Anal Calcd for C19H13N3O2:
C, 72.37; H, 4.16; N, 13.33. Found: C, 72.34; H, 4.15; N, 13.35.
20
Tetrahydroluotonin
A (20)
Yield 190 mg (50%); mp 191-193 ˚C. ¹H
NMR (400 MHz, CDCl3): δ = 2.57 (dd, J = 8.0, 14.8
Hz, 1 H), 2.95-3.06 (m, 2 H), 4.03 (dd, J = 4.0,
12.0 Hz, 1 H), 4.33 (dd, J = 6.8,
12 Hz, 1 H), 4.66 (s, 1 H), 4.81 (dd, J = 3.2,
7.8 Hz, 1 H), 6.65 (d, J = 6.7
Hz, 1 H), 6.70 (dd, J = 0.4,
10.6 Hz, 1 H), 7.01 (m, 2 H) 7.45 (m, 1 H), 7.72-7.80 (m,
2 H), 8.29 (d, J = 8.4
Hz, 1 H). ¹³C NMR (400 MHz, CDCl3): δ = 28.5,
31.6, 49.7, 57.6, 114.3, 118.6, 120.0, 121.1, 126.4, 126.7, 127.1,
127.6, 128.8, 134.2, 142.6, 149.2, 159.5, 160.9. MS: m/z (%) = 435 [M + 1],
290.2, 202.2, 186.2. Anal Calcd for C18H15N3O:
C, 74.72; H, 5.23; N, 14.52. Found: C, 74.70; H, 5.21; N, 14.57.